Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome [NA]

View source ↗

Summary

This clinical trial update compares Curosurf (poractant alfa) with Infasurf (beractant) for the treatment of respiratory distress syndrome in preterm infants. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curosurf (poractant alfa)
  • INFASURF (calfactant)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Respiratory Distress Syndrome | NA | Status: COMPLETED | Results posted: 2017-06-06